Publications by authors named "Scott Avecilla"

Claim this Profile
A
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components.
Allison P Wheeler, Edward L Snyder, Majed Refaai, Claudia S Cohn, Jessica Poisson, Scott T Avecilla

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components.
Edward L Snyder, Allison P Wheeler, Majed Refaai, Claudia S Cohn, Jessica Poisson, Scott T Avecilla

Transfusion· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT.
Roni Shouval, Joshua A Fein, Christina Cho, Scott T Avecilla, Josel Ruiz

Blood Adv· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation.
Madhavi Lakkaraja, Michael Scordo, Audrey Mauguen, Christina Cho, Sean Devlin, Scott T Avecilla

Blood Adv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.
Scott T Avecilla, Farid Boulad, Karina Yazdanbakhsh, Michel Sadelain, Patricia A Shi

Transfusion· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
Reuben P Jacob, Jessica Flynn, Sean M Devlin, Molly Maloy, Sergio A Giralt, Scott T Avecilla

Transplant Cell Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization.
Jian Chen, Hillard M Lazarus, Parastoo B Dahi, Scott Avecilla, Sergio A Giralt

Blood Rev· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simplified CD34+ based preharvest prediction tool for HPC(A) collection.
Reuben P Jacob, Eileen M Walsh, Peter G Maslak, Sergio A Giralt, Scott T Avecilla

Transfusion· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin.
Ioannis Politikos, Sean M Devlin, Maria E Arcila, Jonathan C Barone, Molly A Maloy, Scott T Avecilla

Leukemia· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy.
Elizabeth F Stone, Scott T Avecilla, David L Wuest, Christine Lomas-Francis, Connie M Westhoff

Haematologica· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34-selected allogeneic transplantation.
Christina Cho, Patrick Hilden, Scott T Avecilla, Juliet N Barker, Hugo Castro-Malaspina

Adv Cell Gene Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults.
Juliet N Barker, Sean M Devlin, Kristine A Naputo, Kelcey Skinner, Molly A Maloy, Scott T Avecilla

Blood Adv· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for Cord Blood Unit Thaw and Infusion.
Andromachi Scaradavou, Scott T Avecilla, Joann Tonon, Ioannis Politikos, Mitchell E Horwitz

Biol Blood Marrow Transplant· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple Myeloma.
Susan Bal, Heather J Landau, Gunjan L Shah, Michael Scordo, Parastoo Dahi, Scott Avecilla

Biol Blood Marrow Transplant· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel method for the laboratory workup of anaphylactic transfusion reactions in haptoglobin-deficient patients.
Katie L Thoren, Scott T Avecilla, Virginia Klimek, Cheryl Goss

Transfusion· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of thymoma-associated pure red cell aplasia: A novel use of blood substitute HBOC-201 in a Jehovah's Witness.
Maria M Rubinstein, Cheryl Goss, Scott T Avecilla, Gregory P Dubé, Gregory J Riely

Clin Case Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma.
Tania Jain, Craig S Sauter, Gunjan L Shah, Molly A Maloy, Jason Chan, Scott T Avecilla

Leukemia· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34 Selected Allogeneic Hematopoietic Cell Transplantation.
Michael Scordo, Valkal Bhatt, Patrick Hilden, Melody Smith, Katie Thoren, Scott T Avecilla

Biol Blood Marrow Transplant· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Michael Scordo, Meier Hsu, Ann A Jakubowski, Gunjan L Shah, Christina Cho, Scott T Avecilla

Biol Blood Marrow Transplant· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of peripheral blood mononuclear cell collection by leukapheresis.
Jian Chen, Cheryl Goss, Scott T Avecilla, Hong Hong, Eileen Walsh

Transfusion· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational use of PEGylated carboxyhemoglobin bovine in a Jehovah's Witness with hemorrhagic shock.
Robert A DeSimone, David A Berlin, Scott T Avecilla, Cheryl A Goss

Transfusion· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Method comparison study of peripheral blood CD34+ count performed on an Abbott CELL-DYN Sapphire hematology analyzer versus flow cytometry reference procedure (modified ISHAGE).
Scott T Avecilla, Cheryl Goss, Steven M Marionneaux, Donald R Wright, Tyler D Leiva

Adv Cell Gene Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.
Michael Scordo, Gunjan L Shah, Satyajit Kosuri, Diego Adrianzen Herrera, Christina Cho, Scott T Avecilla

Biol Blood Marrow Transplant· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Toxicity on Survival for Older Adult Patients after CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation.
Gunjan L Shah, Michael Scordo, Satyajit Kosuri, Diego Adrianzen Herrera, Christina Cho, Scott T Avecilla

Biol Blood Marrow Transplant· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.
Satyajit Kosuri, Diego Adrianzen Herrera, Michael Scordo, Gunjan L Shah, Christina Cho, Scott T Avecilla

Biol Blood Marrow Transplant· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis